Back to today’s briefing

Story perspectives

Kennedy Lauds Trump's Weight Loss Drug Pricing Deal

11/15/2025

46 9

Summary

Story summary

Robert F. Kennedy Jr., the U.S. health secretary, praised U.S. President Donald Trump’s weight loss drug pricing deal.
The deal aims to lower costs and expand Medicare coverage for obesity treatments.
Kennedy’s praise signals a shift from earlier criticisms that labeled these drugs harmful.
TrumpRx will roll out by end of 2025, with full Medicare integration by mid-2026.

1 of 1

Story summary

Robert F. Kennedy Jr., the U.S. health secretary, praised U.S. President Donald Trump’s weight loss drug pricing deal.
The deal aims to lower costs and expand Medicare coverage for obesity treatments.
Kennedy’s praise signals a shift from earlier criticisms that labeled these drugs harmful.
TrumpRx will roll out by end of 2025, with full Medicare integration by mid-2026.